摘要
目的:研究84例非小细胞肺癌中nm23-H1的表达及与淋巴结转移的关系,探讨其在非小细胞肺癌中表达的意义及预后的联系。方法:用免疫组化LSAB方法检测肺癌石蜡组织中nm23-H1的表达;结果:59.6%的腺癌和54.1%的鳞癌有nm23-H1的表达;在有淋巴结转移的肺癌中nm23-H1表达的阳性率为21.9%,而无淋巴结转移的肺癌中其表达率高达78.8%,两者差异有显著性。结论:nm23-H1的表达与非小细胞肺癌的淋巴结转移呈负相关,其可能抑制淋巴结的转移过程,是观察预后的一个重要指标。
Objective To investigate the expression of
nm23 H1 innon small cell lung cancer.and its relationship with lymph node metastasis Method
With immunohistochemical analysis.Results The results showed that 59 6% of the
adenocarcinomas and 54 1% of the aquamous cell carcinomas had the expression of nm23
H1,and there was no significant difference between them.Only 21 9% of the lung cancer with
metastasis of lymph nodes had the expression of nm23 H1,but 78 8% with no metastasis had
the expression of nm23 H1.And the difference between them was significant.Conclusion It
suggests that the expression of nm23 H1 is negativety correlated to metastasis in lymph
nodes of non samll cell lung cancer,it may inhibit the metastasis process of lymph nodes,and
can be considered as one of the indexes for the prognosis of non small cell lung cancer.
出处
《中国民康医学》
1999年第1期27-28,64-65,共4页
Medical Journal of Chinese People’s Health
关键词
非小细胞肺癌
淋巴结转移
NM23-H1
免疫组化
non small cell lung cancer
metastasis of lymph nodes
nm23 H1
immunohisto
chemistry